CIK 0001714899
- Large accelerated filer
Denali Therapeutics Inc.
Sign in to watch- Ticker
- DNLI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 463872213
- Phone
- +1 650-866-8547
- Business address
- 161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $363,678
- in 3 filings, $327K under 10b5-1 plans
Net −$363,678. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-03 | Krognes Steve E. Director | Grant or award | +6,408 | 38,202 | ||
| 2026-06-03 | Krognes Steve E. Director | Grant or award · Stock Option (right to buy) | +19,226 | 19,226 | ||
| 2025-06-03 | Krognes Steve E. Director | Grant or award | +6,037 | 31,794 | ||
| 2025-06-03 | Krognes Steve E. Director | Grant or award · Stock Option (right to buy) | +18,111 | 18,111 | ||
| 2025-01-07 | Krognes Steve E. Director | Sale | −3,339 | $20.81 | $69K | 25,757 |
| 2024-12-31 | Krognes Steve E. Director | Sale 10b5-1 | −30,000 | $20.25 | $608K | 29,096 |
| 2024-09-30 | Krognes Steve E. Director | Sale 10b5-1 | −30,000 | $29.03 | $871K | 29,096 |
| 2024-08-20 | Krognes Steve E. Director | Sale | −1,727 | $23.79 | $41K | 32,677 |
| 2024-07-01 | Krognes Steve E. Director | Sale 10b5-1 | −29,900 | $22.12 | $661K | 34,504 |
| 2024-07-01 | Krognes Steve E. Director | Sale 10b5-1 | −100 | $22.80 | $2K | 34,404 |
| 2024-06-13 | Krognes Steve E. Director | Sale 10b5-1 | −688 | $21.79 | $15K | 52,620 |
| 2024-05-31 | Krognes Steve E. Director | Grant or award | +5,967 | 53,308 | ||
| 2024-05-31 | Krognes Steve E. Director | Grant or award · Stock Option (right to buy) | +17,901 | 17,901 | ||
| 2024-04-01 | Krognes Steve E. Director | Sale 10b5-1 | −92,500 | $20.50 | $1.9M | 47,341 |
| 2024-02-13 | Krognes Steve E. Director | Sale | −2,750 | $17.29 | $48K | 139,841 |
| 2024-01-05 | Krognes Steve E. Director | Sale | −3,208 | $19.43 | $62K | 142,591 |
| 2023-08-21 | Krognes Steve E. Director | Sale | −1,419 | $22.60 | $32K | 145,799 |
| 2023-06-01 | Krognes Steve E. Director | Grant or award | +4,216 | 147,218 | ||
| 2023-06-01 | Krognes Steve E. Director | Grant or award · Stock Option (right to buy) | +12,649 | 12,649 | ||
| 2023-02-13 | Krognes Steve E. Director | Sale | −2,119 | $30.10 | $64K | 143,002 |
Page 1 of 4 · 70 trades